Answers are grounded in this paper and cite their sources.
Purpose: To evaluate the benefit of scleral lenses (SCL) in eyes with surgical aphakia after cataract surgery in patients diagnosed with chronic cicatrizing conjunctivitis (CCC) and advanced keratopathy with severe aqueous deficient dry eye disease (ADDE). Methods: This retrospective study included eyes which underwent cataract surgery and were left aphakic, followed by fitting with SCLs. The primary outcome was the improvement in best-corrected visual acuity (BCVA) with SCLs. Results: Eighteen eyes of 15 patients were included. The most common etiology of CCC was Stevens–Johnson syndrome (72.2%). Severe ADDE was observed in 100% eyes. The majority of cataract surgeries were performed using small incision cataract surgery and phacoemulsification techniques. The median preoperative BCVA was 1.7 logMAR (interquartile range [IQR]: 1.3–2.2). At 6 weeks after surgery, median BCVA without SCL improved to logMAR 1.5 (IQR: 1.2–1.8) ( P =0.022). The median time interval between cataract surgery and the initiation of SCL use was 1.5 (IQR: 1–2.75) months. The median follow-up period after lens dispensing was 19 (IQR: 2.5–45.75) months. At the last follow-up visit, the median BCVA improved from logMAR 1.7 (IQR: 1.3–1.8) without SCL to logMAR 1.6 (1.3–1.8) with spectacle correction ( P =0.44) to logMAR 0.8 (IQR: 0.7–1.2) with SCL ( P <0.001). Conclusions: In surgically aphakic eyes with advanced keratopathy and severe ADDE secondary to CCC, SCL correction provided significantly better visual acuity than aphakic spectacle correction. High-plus aphakic SCLs may require individualized lens-design modifications to reduce lens thickness and optimize oxygen transmission.
No takes yet. Share an insight, caveat, or question.
Chaudhary et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: